Biokimia Farmasi: Integrasi dan Regulasi Metabolisme

Summary

The lecture explains how carbohydrate, lipid, and protein metabolism are integrated; how hormones regulate blood glucose in fed and fasting states; and how disruption of this regulation can lead to diabetes mellitus.

1. Metabolism is interconnected

• Catabolism breaks down molecules and releases energy, while anabolism builds molecules and uses energy.
• The citric acid cycle (also called the Krebs or TCA cycle) is a shared, amphibolic pathway linking the metabolism of carbohydrates, fats, and proteins:
  • Carbohydrates are broken down through glycolysis to pyruvate, which is then converted to acetyl-CoA.
  • Glycerol from fats can enter glycolysis, while fatty acids undergo beta-oxidation to produce acetyl-CoA.
  • Amino acids can enter metabolic pathways after their nitrogen is removed. Nitrogen is disposed of through urea formation.
• Acetyl-CoA and other intermediates feed into the citric acid cycle and oxidative phosphorylation to support ATP production.

2. Hormones regulate blood glucose

• Insulin, released by pancreatic beta cells when blood glucose rises, lowers blood glucose by promoting glucose uptake and storage.
• Glucagon, released by pancreatic alpha cells when glucose is low, raises blood glucose by promoting glycogen breakdown and glucose production.
• Epinephrine (adrenaline) raises blood glucose, including by stimulating glycogen breakdown.
• Cortisol and growth hormone help maintain or raise blood glucose, including by supporting glucose production or limiting glucose use by some tissues.
• Somatostatin, produced by pancreatic delta cells, helps regulate insulin and glucagon secretion.
• In blood-glucose regulation, insulin generally opposes glucagon and epinephrine.

3. Responses in fed and fasting states

After eating (fed state)

• Rising blood glucose stimulates insulin secretion.
• Glucose is used for energy through glycolysis and related pathways.
• Excess glucose can be stored as glycogen; excess energy may also be stored as triglycerides.
• Glycogen formation and fat synthesis increase, while glycogen breakdown, fat breakdown, and gluconeogenesis generally decrease.

During fasting

• Falling blood glucose reduces insulin secretion and promotes glucagon release.
• Glycogen is broken down to help maintain blood glucose.
• Fat stores are mobilized through lipolysis to provide energy.
• During prolonged fasting, gluconeogenesis produces glucose from non-carbohydrate precursors, including lactate and amino-acid-derived compounds.

4. How glucose stimulates insulin release

The lecture outlines the following sequence in pancreatic beta cells:

1. Glucose enters the cell through a glucose transporter.
2. Glucose metabolism raises intracellular ATP.
3. ATP-sensitive potassium channels close, changing the cell’s electrical state.
4. Depolarization opens voltage-sensitive calcium channels.
5. Calcium enters the cell and triggers insulin-containing granules to release insulin into the bloodstream.

Insulin then binds to its receptor and activates intracellular signaling. In muscle and adipose tissue, this promotes GLUT4 movement to the cell membrane, increasing glucose uptake. Cells can use glucose for energy or store it, including as glycogen.

5. Diabetes mellitus: causes, effects, and complications

• Diabetes mellitus is a metabolic disorder involving persistent high blood glucose, associated with insufficient insulin, insulin resistance, or both.
• Type 1 diabetes is associated with major loss or damage of pancreatic beta cells and severe insulin deficiency; insulin treatment is required.
• Type 2 diabetes commonly begins with insulin resistance and may progress to reduced beta-cell function and insulin deficiency. The lecture highlights lifestyle factors such as excess energy intake, obesity, dyslipidemia, and lack of exercise, while also noting genetic contributions.
• The lecture also mentions gestational diabetes and diabetes associated with other conditions or medications.
• Common symptoms discussed include frequent urination (polyuria), excessive thirst (polydipsia), increased hunger (polyphagia), fatigue, blurred vision, numbness, slow-healing wounds, and sometimes unexplained weight loss.
• Possible complications include retinopathy, nephropathy, neuropathy, cardiovascular disease, stroke, and sexual dysfunction. Complications may develop without obvious early symptoms.
• Diagnosis and monitoring are discussed in terms of laboratory testing, including fasting or post-meal glucose, glucose-tolerance testing, and HbA1c. Exact numerical thresholds in the transcript are unclear and may have been mistranscribed.

6. Diabetes management and the pharmacist’s role

The lecture presents diabetes management as involving both lifestyle measures and medication:

• Support dietary changes, regular exercise, and weight management; avoid smoking and excess alcohol.
• Use medication when indicated, including insulin or oral glucose-lowering drugs.
• Drug classes mentioned include:
  • Alpha-glucosidase inhibitors, which reduce carbohydrate absorption.
  • Metformin (a biguanide), which reduces hepatic glucose production and supports glucose handling.
  • Sulfonylureas and meglitinides, which stimulate insulin secretion.
  • Thiazolidinediones, which improve insulin sensitivity.
• Pharmacists can educate patients about the condition, medication use and storage, adherence, possible side effects, and prevention of complications, working with the treating clinician as needed.
• The lecture warns that hypoglycemia can occur with treatment. Sweating and tremors are among the symptoms mentioned; patients should be taught to recognize and respond to them.

7. Relationship between high blood lipids and type 2 diabetes

As a follow-up case, the lecturer asks students to explain how hyperlipidemia or dyslipidemia may contribute to insulin resistance. Proposed mechanisms include:

• Excess fatty acids and obesity can interfere with insulin signaling and GLUT4 movement to the cell membrane.
• Reduced GLUT4-mediated glucose uptake in muscle and adipose tissue can contribute to elevated blood glucose.
• Inflammatory signals, including TNF-alpha, and oxidative stress may further impair insulin action.
• The body may initially compensate by producing more insulin, but persistent metabolic stress can contribute to declining beta-cell function and progression toward type 2 diabetes.

Speakers and sources featured

• Speaker: One lecturer or narrator teaching the pharmaceutical biochemistry course; no guest speakers are identified.
• Sources and materials mentioned: The lecturer refers students to textbooks, journals, diabetes-related guidelines or standards, and DiPiro’s Pharmacotherapy. Students are also directed to the course module’s evaluation questions and asked to use supporting references for the hyperlipidemia–insulin resistance case.